FIELD: medicine.
SUBSTANCE: there are described compounds of formula in a free form or in the form of salt where R1 and R2 have values specified in the description of the application which are used for treating inflammatory conditions, first of all inflammatory or obstructive respiratory tract diseases. Besides the application describes the pharmaceutical compositions containing said compounds, and methods for preparing said compounds.
EFFECT: compounds exhibits improved efficiency.
5 cl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT HAVING ANTIOXIDANT, HEPATOPROTECTOR AND ANTI-INFLAMMATORY PROPERTIES | 2010 |
|
RU2436793C1 |
SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
BETA-LACTAMS | 1995 |
|
RU2143435C1 |
REGULATORS-DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND THEIR USE | 2019 |
|
RU2797408C2 |
NOVEL OPTICALLY ACTIVE 4-HYDROXY-2-AZA-9,10-ANTHRAQUINONES, HAVING ANTIINFLAMMATORY ACTIVITY, AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2436775C1 |
NEW CRYSTAL FORM OF VASCULAR PERMEABILITY BLOCKER COMPOUND | 2020 |
|
RU2809162C2 |
CRYSTALLINE MODIFICATION OF PARA-METHOXYANILIDE OF 6-HYDROXY-4-OXO-2,4-DIHYDRO-1H-PYRROLO[3,2,1-ij]QUINOLINE-5-CARBOXYLIC ACID | 2012 |
|
RU2480468C1 |
PROCESS FOR PREPARING DERIVATIVES OF BENZO(C)QUINOLINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 0 |
|
SU1098520A3 |
BENZYLURSONATE - ANTI-INFLAMMATORY AND HEPATOPROTECTIVE AGENT | 2010 |
|
RU2430106C1 |
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR APPLICATION OF 4-PREGNEN-11β-17-21-TRIOL-3,20-DIONE DERIVATIVES | 2012 |
|
RU2683775C2 |
Authors
Dates
2010-04-27—Published
2005-07-13—Filed